Crystallization and preliminary crystallographic studies of antibacterial polypeptide LCI expressed in Escherichia coli

Tools

Zhu, Jia-Peng and Chen, Bing-Zhang and Gong, Wei-Bin and Liang, Yu-He and Wang, Huan-Chen and Xu, Qing and Chen, Zhang-Liang and Lu, Guang-Ying (2001) Crystallization and preliminary crystallographic studies of antibacterial polypeptide LCI expressed in Escherichia coli. Acta Crystallographica Section D: Biological Crystallography, D57 (12). pp. 1931-1932. ISSN 0907-4449 (https://doi.org/10.1107/S0907444901017280)

[thumbnail of Zhu-etal-ACSD-2001-Crystallization-and-preliminary-crystallographic-studies-of-antibacterial-polypeptide]
Preview
 Text. Filename: Zhu_etal_ACSD_2001_Crystallization_and_preliminary_crystallographic_studies_of_antibacterial_polypeptide.pdf
Final Published Version
Download (175kB)| Preview

Abstract

LCI is a type of novel antibacterial polypeptide secreted by a Bacillus subtilis strain. It consists of 47 residues with a molecular weight of 5468 Da. Using bioengineering, LCI was expressed in Escherichia coli DH5α with recombinant plasmid pBVAB16. It was crystallized using PEG 4000 as a precipitant. The crystal belongs to space group P6222 or P6422, with unit-cell parameters a = b = 29.30, c = 187.09 Å, and diffracts to 2.44 Å. A set of diffraction data to 2.8 Å was collected.

ORCID iDs

Zhu, Jia-Peng, Chen, Bing-Zhang ORCID logoORCID: https://orcid.org/0000-0002-1573-7473, Gong, Wei-Bin, Liang, Yu-He, Wang, Huan-Chen, Xu, Qing, Chen, Zhang-Liang and Lu, Guang-Ying;
CORE (COnnecting REpositories)